Lydia’s practice is focused on complex patent and trademark litigation involving a variety of technologies.
During law school, Lydia worked with Washington University’s Entrepreneurship & Intellectual Property Clinic where she counseled nonprofits and startups on intellectual property matters and business entity formation. Lydia was also a judicial intern for the Hon. Judge Audrey Fleissig in the U.S. District Court for the Eastern District of Missouri where she conducted research, assisted in drafting and editing opinions and prepared bench briefs.
While an undergraduate majoring in chemistry, Lydia studied chemicals known to target sigma-1 receptors in the brain, which are a likely target for treating substance abuse. Under the mentorship of Dr. Susan Z. Lever, she wrote an honors thesis on novel methods of synthesizing spipethiane analogs for use in receptor binding studies.
Lydia Raw, Are We Adopting the Orphans, or Creating Them? Medical Ethics and Legal Jurisprudential Guidance for Proposed Changes to the Orphan Drug Act, 9 Wash. U. Jur. Rev. 295 (2017).